322 related articles for article (PubMed ID: 34800742)
1. Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.
Faycal A; Ndoadoumgue AL; Sellem B; Blanc C; Dudoit Y; Schneider L; Tubiana R; Valantin MA; Seang S; Palich R; Bleibtreu A; Monsel G; Godefroy N; Itani O; Paccoud O; Pourcher V; Caumes E; Ktorza N; Chermak A; Abdi B; Assoumou L; Katlama C;
Infect Dis Now; 2022 Mar; 52(2):75-81. PubMed ID: 34800742
[TBL] [Abstract][Full Text] [Related]
2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
[TBL] [Abstract][Full Text] [Related]
4. Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up.
Seang S; Itani O; Monsel G; Abdi B; Marcelin AG; Valantin MA; Palich R; Fayçal A; Pourcher V; Katlama C; Tubiana R
Infect Dis Now; 2022 May; 52(3):165-169. PubMed ID: 35158095
[TBL] [Abstract][Full Text] [Related]
5. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study.
Armange L; Bénézit F; Picard L; Pronier C; Guillot S; Lentz PA; Carré F; Tattevin P; Revest M
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2421-2425. PubMed ID: 33893570
[TBL] [Abstract][Full Text] [Related]
8. High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study.
Poncet-Megemont L; Paris P; Tronchere A; Salazard JP; Pereira B; Dallel R; Aumeran C; Beytout J; Jacomet C; Laurichesse H; Lesens O; Mrozek N; Vidal M; Moisset X
Headache; 2020 Nov; 60(10):2578-2582. PubMed ID: 32757419
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study.
da Costa E Silva GR; Moura WÉA; Dos Santos KC; Gomes DO; Bandeira GN; Guimarães RA; Rosso CFW; Bazilio GS; Leite VRMC; Caetano KAA; Carneiro MADS; Teles SA
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674238
[TBL] [Abstract][Full Text] [Related]
10. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample.
Caplan A; Bates KW; Brioni C; Santos A; Sabatini LM; Kaul KL; Carnethon MR; Khandekar JD; Greenland P
PLoS One; 2021; 16(10):e0258970. PubMed ID: 34673816
[TBL] [Abstract][Full Text] [Related]
12. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study.
Nouchi A; Chastang J; Miyara M; Lejeune J; Soares A; Ibanez G; Saadoun D; Morélot-Panzini C; Similowski T; Amoura Z; Boddaert J; Caumes E; Bleibtreu A; Lorenzo A; Tubach F; Pourcher V
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):691-697. PubMed ID: 33033955
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study.
Yordanov Y; Dinh A; Bleibtreu A; Mensch A; Lescure FX; Debuc E; Jourdain P; Jaulmes L; Dechartres A;
Clin Microbiol Infect; 2021 Aug; 27(8):1158-1166. PubMed ID: 33915287
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Anosmia in 10.157 Pediatric COVID-19 Cases: Multicenter Study from Turkey.
Elvan-Tuz A; Karadag-Oncel E; Kiran S; Kanik-Yuksek S; Gulhan B; Hacimustafaoglu M; Ozdem-Alatas S; Kuyucu N; Ozdemir H; Egil O; Elmas-Bozdemir S; Polat M; Bursal-Duramaz B; Cem E; Apaydin G; Teksam O;
Pediatr Infect Dis J; 2022 Jun; 41(6):473-477. PubMed ID: 35349499
[TBL] [Abstract][Full Text] [Related]
16. Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
Desgranges F; Tadini E; Munting A; Regina J; Filippidis P; Viala B; Karachalias E; Suttels V; Haefliger D; Kampouri E; Van Singer M; Tschopp J; Rochat Stettler L; Schaad S; Brahier T; Hugli O; Mueller Y; Gouveia A; Opota O; Carron PN; Guery B; Papadimitriou-Olivgeris M; Boillat-Blanco N;
J Gen Intern Med; 2022 Jun; 37(8):1943-1952. PubMed ID: 35319081
[TBL] [Abstract][Full Text] [Related]
17. Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness.
Blair JE; Gotimukul A; Wang F; Mina SA; Bartels HC; Burns MW; Kole AE; Vikram HR; Gea-Banacloche JC; Seville MT; Petty SAB; Vikram A; Orenstein R
Medicine (Baltimore); 2021 Jun; 100(24):e26371. PubMed ID: 34128896
[TBL] [Abstract][Full Text] [Related]
18. COVID-19's natural course among ambulatory monitored outpatients.
Weinbergerova B; Mayer J; Hrabovsky S; Novakova Z; Pospisil Z; Martykanova L; Hortova K; Mandelova L; Hejduk K; Chloupková R; Pospisil M; Doubkova M; Marek V; Novotna R; Dolecek M; Kubesova HM; Brat K; Parizkova R; Husa P; Mechl M; Kral Z; Lengerova M
Sci Rep; 2021 May; 11(1):10124. PubMed ID: 33980931
[TBL] [Abstract][Full Text] [Related]
19. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
20. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
